ArticleMethods in molecular biology (Clifton, N.J.)2026
A Versatile Ribo-seq Workflow for Enhanced Analysis of Ribosome Dynamics.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ribosome profiling (or ribo-sequencing) is a powerful technique that enables high-resolution analysis of active translation by sequencing ribosome-protected mRNA fragments. Developed in 2009 by Nicholas Ingolia and Jonathan Weissman, it provides direct insights into which mRNAs are being translated and at what rate, surpassing traditional transcriptomic and proteomic methods. Ribo-seq allows for precise mapping of ribosome positions, enabling detailed characterization of ribosome dynamics and the identification of alternative translation initiation sites and upstream open reading frames. The standard workflow includes key steps such as ribosome stabilization, nuclease digestion, fragment isolation, and deep sequencing. The protocol described in this chapter incorporates a polysome profiling step prior to RNase treatment, allowing, for instance, the isolation of distinct ribosome species (also known as k-somes). Ribo-seq has transformed our understanding of translational regulation and has become an essential tool for omics studies in various fields such as developmental biology, cancer biology, virology, and microbiology.
Indexed as
Identifiers
41269562What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.